All lobbying filings
THORN RUN PARTNERS
THORN RUN PARTNERS filed a Q1 report for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. on April 16, 2025, reporting $50,000 in lobbying income.
Lobbying for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · pharmaceutical company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 16, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
Connecticut
Lobbyists on this filing
1
-
BEAU SCHUYLERPreviously held: Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre
Government bodies contacted
2
Lobbying activity
1
Policies related to creating incentives for innovation in the life sciences.